Back to Search
Start Over
Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles.
- Source :
-
Journal of pharmaceutical sciences [J Pharm Sci] 1998 Jan; Vol. 87 (1), pp. 96-100. - Publication Year :
- 1998
-
Abstract
- Indeloxazine hydrochloride (IDX), a cerebral activator, has a bitter astringent taste. To prepare powders of IDX without this bitter taste, microparticles (median diameter, 130 microns) of IDX were coated with a mixture comprising hydrogenated oil and surfactants in a fluidized bed using the side-spray method. Drug release from the resulting coated particles was significantly delayed. Dissolution rate was remarkably enhanced, however, by heat-treating the coated particles at a temperature above the melting point of the surfactant in the coated layer. The results of differential scanning calorimetry measurements show that part of the surfactant in the coated layer exists separately. Further, surface changes in the coated layer before and after heat treatment showed that this enhancement of dissolution rate was due to rediffusion of the surfactant in the coated layer followed by melting of the surfactant. This effect allows the design of powders of IDX which release the drug quickly and with bioequivalence to the commercial IDX 20 mg tablets while sufficiently suppressing the bitter taste.
- Subjects :
- Antidepressive Agents administration & dosage
Antidepressive Agents pharmacokinetics
Biological Availability
Cross-Over Studies
Drug Compounding
Hot Temperature
Humans
Male
Microscopy, Electron, Scanning
Morpholines administration & dosage
Morpholines pharmacokinetics
Poloxalene
Powders
Solubility
Antidepressive Agents chemistry
Morpholines chemistry
Taste
Subjects
Details
- Language :
- English
- ISSN :
- 0022-3549
- Volume :
- 87
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of pharmaceutical sciences
- Publication Type :
- Academic Journal
- Accession number :
- 9452976
- Full Text :
- https://doi.org/10.1021/js970104g